An ensemble learning approach for modeling the systems biology of drug-induced injury
| Autor: | Giulia Callegaro, Ferran Sanz, Narcis Fernandez-Fuentes, Janet Piñero, Terezinha Souza, Joaquim Aguirre-Plans, Steven J. Kunnen, Laura I. Furlong, Baldo Oliva, Emre Guney |
|---|---|
| Přispěvatelé: | Toxicogenomics, RS: GROW - R1 - Prevention |
| Jazyk: | angličtina |
| Rok vydání: | 2021 |
| Předmět: |
Drug
EXPRESSION GENES Drug-induced liver injury Drug-Related Side Effects and Adverse Reactions PREDICTION media_common.quotation_subject Systems biology Immunology Drug structure Computational biology Biology Models Biological General Biochemistry Genetics and Molecular Biology Machine Learning 03 medical and health sciences 0302 clinical medicine Feature (machine learning) Humans Liver damage Drug safety lcsh:QH301-705.5 Ecology Evolution Behavior and Systematics 030304 developmental biology media_common RISK 0303 health sciences INDUCED LIVER-INJURY Applied Mathematics Research Systems Biology Hepatotoxicity Robustness (evolution) PLATFORM Gene signature Ensemble learning 3. Good health Cmap lcsh:Biology (General) Pharmaceutical Preparations 030220 oncology & carcinogenesis Modeling and Simulation CONNECTIVITY MAP Research studies Chemical and Drug Induced Liver Injury General Agricultural and Biological Sciences CAMDA |
| Zdroj: | Biology Direct Biology Direct, 16(1):5. BioMed Central Biology Direct, Vol 16, Iss 1, Pp 1-14 (2021) |
| ISSN: | 1745-6150 |
| Popis: | Background: Drug-induced liver injury (DILI) is an adverse reaction caused by the intake of drugs of common use that produces liver damage. The impact of DILI is estimated to affect around 20 in 100,000 inhabitants worldwide each year. Despite being one of the main causes of liver failure, the pathophysiology and mechanisms of DILI are poorly understood. In the present study, we developed an ensemble learning approach based on different features (CMap gene expression, chemical structures, drug targets) to predict drugs that might cause DILI and gain a better understanding of the mechanisms linked to the adverse reaction. Results: We searched for gene signatures in CMap gene expression data by using two approaches: phenotype-gene associations data from DisGeNET, and a non-parametric test comparing gene expression of DILI-Concern and No-DILI-Concern drugs (as per DILIrank definitions). The average accuracy of the classifiers in both approaches was 69%. We used chemical structures as features, obtaining an accuracy of 65%. The combination of both types of features produced an accuracy around 63%, but improved the independent hold-out test up to 67%. The use of drug-target associations as feature obtained the best accuracy (70%) in the independent hold-out test. Conclusions: When using CMap gene expression data, searching for a specific gene signature among the landmark genes improves the quality of the classifiers, but it is still limited by the intrinsic noise of the dataset. When using chemical structures as a feature, the structural diversity of the known DILI-causing drugs hampers the prediction, which is a similar problem as for the use of gene expression information. The combination of both features did not improve the quality of the classifiers but increased the robustness as shown on independent hold-out tests. The use of drug-target associations as feature improved the prediction, specially the specificity, and the results were comparable to previous research studies. The authors received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreements TransQST and eTRANSAFE (refs: 116030, 777365). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA companies in kind contribution. The authors also received support from Spanish Ministry of Economy (MINECO, refs: BIO2017–85329-R (FEDER, EU), RYC-2015-17519) as well as EU H2020 Programme 2014–2020 under grant agreement No. 676559 (Elixir-Excelerate) and from Agència de Gestió D’ajuts Universitaris i de Recerca Generalitat de Catalunya (AGAUR, ref.: 2017SGR01020). L.I.F. received support from ISCIII-FEDER (ref: CPII16/00026). The Research Programme on Biomedical Informatics (GRIB) is a member of the Spanish National Bioinformatics Institute (INB), PRB2-ISCIII and is supported by grant PT13/0001/0023, of the PE I + D + i 2013–2016, funded by ISCIII and FEDER. The DCEXS is a “Unidad de Excelencia María de Maeztu”, funded by the MINECO (ref: MDM-2014-0370). J.A.P. received support from the CAMDA Travel Fellowship. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink